Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 2
2000 pubmed

The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin.

Kim. M S MS; Small. C J CJ; Stanley. S A SA; Morgan. D G DG; Seal. L J LJ; Kong. W M WM; Edwards. C M CM; Abusnana. S S; Sunter. D D; Ghatei. M A MA; Bloom. S R SR

Key Findings

  • Central alpha‑MSH analog raises TSH and T4 in fasted rats
  • AgRP (a melanocortin blocker) lowers TSH and T4 when given into the brain
  • Alpha‑MSH stimulates TRH release from hypothalamus; AgRP blocks this effect
  • Leptin’s ability to increase TRH is also blocked by AgRP

Practical Outcomes

  • Melanotan‑I, an alpha‑MSH analog, might influence thyroid hormone production, which could affect metabolism, but the experiments used direct brain injections in rats, not the skin‑applied doses typical for humans. For biohackers, the finding is interesting but not yet a reliable protocol for boosting thyroid function; more human data are needed before practical use.

Summary

The study shows that activating the brain's melanocortin system (like with an alpha‑MSH mimic) can boost thyroid‑stimulating hormone and thyroid hormone levels in rats, while blocking this system with AgRP does the opposite. This links the melanocortin pathway to the thyroid axis, especially during fasting.

Abstract

Prolonged fasting is associated with a downregulation of the hypothalamo-pituitary thyroid (H-P-T) axis, which is reversed by administration of leptin. The hypothalamic melanocortin system regulates energy balance and mediates a number of central effects of leptin. In this study, we show that hypothalamic melanocortins can stimulate the thyroid axis and that their antagonist, agouti-related peptide (Agrp), can inhibit it. Intracerebroventricular (ICV) administration of Agrp (83-132) decreased plasma thyroid stimulating hormone (TSH) in fed male rats. Intraparaventricular nuclear administration of Agrp (83-132) produced a long-lasting suppression of plasma TSH, and plasma T4. ICV administration of a stable alpha-MSH analogue increased plasma TSH in 24-hour-fasted rats. In vitro, alpha-MSH increased thyrotropin releasing hormone (TRH) release from hypothalamic explants. Agrp (83-132) alone caused no change in TRH release but antagonized the effect of alpha-MSH on TRH release. Leptin increased TRH release from hypothalami harvested from 48-hour-fasted rats. Agrp (83-132) blocked this effect. These data suggest a role for the hypothalamic melanocortin system in the fasting-induced suppression of the H-P-T axis.

Study Information

Provider

pubmed

Year

2000

DOI

10.1172/jci8857